34 research outputs found
Radionuclide therapy using I-131-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression
Introduction Anti-epidermal growth factor receptor (EGFR)-targeted nanoparticles can be used to deliver a therapeutic and imaging agent to EGFR-overexpressing tumor cells. I-131-labeled anti-EGFR nanoparticles derived from cetuximab were used as a tumor-targeting vehicle in radionuclide therapy
Mapping the Archaeology of Somaliland: Religion, Art, Script, Time, Urbanism, Trade and Empire
FdA – Publicaties zonder aanstelling Universiteit LeidenHeritage of Indigenous People
South-South cooperation in health: bringing in theory, politics, history, and social justice
Recommended from our members